Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Hematologic Malignancies
Related studies linked through entity extraction aliases.
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors
- Status
- COMPLETED
- Phase
- N/A
Therapy for Progressive and/or Refractory Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Treg Cells for AGVHD in Non-myeloablative UCB Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety of Romiplostim (Nplate®) Following UCBT
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
LGX818 for Patients With BRAFV600 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
- Status
- AVAILABLE
- Phase
- N/A
An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate
- Status
- COMPLETED
- Phase
- PHASE1